Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins

American Journal of Human Genetics

Volumn 66, Issue 4, 2000, Pages 1246-1258

  Whitfield, John B ^a,b,d   Cullen, L M ^c   Jazwinska, E C ^c   Powell, L W ^c   Heath, A C ^d   Zhu, G ^c   Duffy, D L ^c   Martin, N G ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c WASHINGTON UNIVERSITY   (United States)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ALLELISM; ARTICLE; BODY MASS; FEMALE; GENETIC POLYMORPHISM; HEREDITY; HUMAN; IRON BLOOD LEVEL; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0033927849     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302862     Document Type: Article

References (45)

1. Aguilar Martinez P, Biron C, Blanc F, Masmejean C, Jeanjean P, Michel H, Schved JF (1997) Compound heterozygotes for hemochromatosis gene mutations: may they help to understand the pathophysiology of the disease? Blood Cells Mol Dis 23:269-276
2. Ajioka RS, Jorde LB, Gruen JR, Yu P, Dimitrova D, Barrow J, Radisky E, et al (1997) Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet 60:1439-1447
3. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH (1999) Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 116:193-207
4. Baynes RD (1994) Iron deficiency. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. WB Saunders, London, pp 189-225
5. Bonkovsky HL, Banner BF, Lambrecht RW, Rubin RB (1996) Iron in liver diseases other than hemochromatosis. Semin Liver Dis 16:65-82
6. Brissot P, Moirand R, Jouanolle AM, Guyader D, Le Gall JY, Deugnier Y, David V (1999) A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J Hepatol 30:588-593
7. Brock JH (1994) Iron in infection, immunity, inflammation and neoplasia. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. WB Saunders, London, pp 353-389
8. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP (1996) Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799-1805
9. Burt MJ, George PM, Upton JD, Collett JA, Frampton CMA, Chapman TM, Walmsley TA, et al (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43:830-836
10. Danesh J, Appleby P (1999) Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 99: 852-854
11. Datz C, Haas T, Rinner H, Sandhofer F, Patsch W, Paulweber B (1998) Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: a protective role against iron deficiency? Clin Chem 44: 2429-2432
12. Edwards CQ, Griffin LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP (1988) Prevalence of hemochromatosis using 11,065 presumably healthy blood donors. N Engl J Med 318:1355-1362
13. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, et al (1996) A novel MHC class 1-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 14:249-251
14. Fulker DW, Cherny SS, Sham PC, Hewitt JK ( 1999) Combined linkage and association sib-pair analysis for quantitative traits. Am J Hum Genet 64:259-267
15. George DK, Powell LW, Losowsky MS (1999) The haemochromatosis gene: a co-factor for chronic liver diseases? J Gastroenterol Hepatol 14:745-749
16. Heath AC, Bucholz KK, Madden PAF, Dinwiddie SH, Slutske WS, Statham DJ, Dunne MP, et al (1997) Genetic and environmental contributions to DSM-IIIR alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med 27:1381-1396
17. Hsing AW, McLaughlin JK, Olsen JH, Mellemkjar L, Wacholder S, Fraumeni JF ( 1995) Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer 60:160-162
18. Jeffrey GP, Chakrabarti S, Hegele RA, Adams PC (1999) Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat Genet 22:325-326
19. Jouanolle AM, Fergelot P, Raoul ML, Gandon G, Roussey M, Deugnier Y, Feingold J, et al (1998) Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis? Ann Genet 41:195-198
20. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F ( 1997) Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96: 3300-3307
21. Kwan T, Leber B, Ahuja S, Carter R, Gerstein HC (1998) Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene. Clin Invest Med 21:251-257
22. Leggett BA, Halliday JW, Brown NN, Powell LW (1990) Prevalence of hemochromatosis amongst asymptomatic Australians. Br J Haematol 74:525-530
23. Lucotte G (1998) Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol Dis 24:433-438
24. Mandishona E, MacPhail AP, Gordeuk VR, Kedda MA, Paterson AC, Rouault TA, Kew MC (1998) Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology 27:1563-1566
25. McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn I. (1999) Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 107:30-37
26. Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Norgaard-Pedersen B, Robson KJ (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13:154-159
27. Moirand R, Jouanolle A-M, Brissot P, Le Gall J-Y, David V, Deugnier Y (1999) Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 116:372-377
28. Mura C, Raguenes O, Ferec C (1999) HFE mutations in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93:2502-2505
29. Murphy S, Curran MD, McDougall N, Callender ME, O'Brien CJ, Middleton D (1998) High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population-implications for haemochromatosis. Tissue Antigens 52: 484-488
30. Neale MC, Cardon LR (1992) Methodology for genetic studies of twins and families. Kluwer, Dordrecht, The Netherlands
31. Nielsen P, Carpinteiro S, Fischer R, Cabeda JM, Porto G, Gabbe EE (1998) Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Br J Haematol 103:842-845
32. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341: 718-724
33. Powell LW, Jazwinska E, Halliday JW (1994) Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) Iron metabolism in health and disease. WB Saunders, London, pp 227-270
34. Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG, Sixma JJ, et al (1999) Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 100:1268-1273
35. Ryan E, O'Keane C, Crowe J (1998) Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis 24:428-432
36. Salter-Cid L, Brunmark A, Li Y, Leturcq D, Peterson PA, Jackson MR, Yang Y (1999) Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: implications for cellular iron homeostasis. Proc Natl Acad Sci USA 96:5434-5439
37. Sampietro M, Fiorelli G, Fargion S (1999) Iron overload in porphyria cutanea tarda. Haematologica 84:248-253
38. Sanchez M, Bruguera M, Bosch J, Rodes J, Ballesta F, Oliva R (1998) Prevalence of Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and controls. J Hepatol 29:725-728
39. Skikne BS, Flowers CH, Cook JD (1990) Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75:1870-1876
40. Stal P (1995) Iron as a hepatotoxin. Dig Dis 13:205-222
41. Steffensen R, Varming K, Jersild C (1998) Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primers. Tissue Anti-gens 52:230-235
42. Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT (1999) Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 100:1274-1279
43. Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT (1998) Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97:1461-1466
44. Zhu G, Duffy DL, Eldridge A, Grace M, Mayne C, O'Gorman L, Aitken JF, et al (1999) A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 65:483-492
45. Zoller H, Pietrangelo A, Vogel W, Weiss G (1999) Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 353:2120-2123